Global Medical Marijuana Market to amass $ 59 Bn by 2025

December 18, 2019


According to the research report titled ‘Medical Marijuana Market Size By Application (Pain Management {Neuropathic Pain, Cancer Pain}, Muscle Spasms, Nausea, Anorexia, Seizures), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, Italy, France, Spain, UK, The Netherlands, Denmark, Ireland, Argentina, Brazil, Chile, Colombia, Mexico, Australia, Israel), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report LLC, the global medical marijuana market is projected to cross USD 59 billion by the year 2025.
 

Rising adoption of medical marijuana for therapeutic solutions, in tandem with its application in treatment of chronic pain caused by arthritis, HIV/AIDS and cancer is aiding the expansion of the market. Widespread legalization of cannabis in various nations, minimal side effects as compared to tradition opioid narcotics, along with its ability to lower the symptoms of nausea and sever pain are further augmenting medical marijuana market growth. 
 

Elaborating on application spectrum, medical marijuana market from cancer pain management segment is expected to register a growth rate of 30% during the forecast period, owing to growing occurrences of cancer across the globe. Cancer pain is caused either when the tumor presses against nerves or bones, or due to chemotherapy drugs.
 

Based on route of administration, oral medical marijuana market is estimated to be worth USD 13.1 billion by the year 2025. Oral consumption of cannabis is safer as compared to smoking the product. In addition to this, factors such as ease of administration and patient convenience are driving the segmental share.  
 

In terms of distribution channel, online segment held 40.1% revenue share of medical marijuana market in 2018. Rising number of US states legalizing medical marijuana through online channels is fueling the growth of the segment.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1230590/
 

Considering geographical landscape, medical marijuana market in the United States is projected to grow by 14.2% through the year 2025. Growing occurrences of chronic pain conditions, in consort with rising consumer awareness regarding the benefits of the product are contributing towards the growth of regional market.  
 

The prominent companies operating in the medical marijuana market are ABcann Medicinals, Inc., Aurora Cannabis, Inc., Canopy Growth Corp., Aphria, Inc., The Supreme Cannabis Co., Tilray, and GW Pharmaceuticals.  


Frequently Asked Questions (FAQ) :

Rising adoption of medical marijuana for therapeutic solutions, in tandem with its application in treatment of chronic pain caused by arthritis, HIV/AIDS and cancer is aiding the expansion of the market. Widespread legalization of cannabis in various nations, minimal side effects as compared to tradition opioid narcotics, along with its ability to lower the symptoms of nausea and sever pain are further augmenting medical marijuana market growth.
Based on route of administration, oral medical marijuana market is estimated to be worth USD 13.1 billion by the year 2025. Oral consumption of cannabis is safe as compared to smoking the product. In addition to this, factors such as ease of administration and patient convenience are driving the segmental share.
Medical marijuana market in the United States is projected to grow by 14.2% through the year 2025. Growing occurrences of chronic pain conditions, in consort with rising consumer awareness regarding the benefits of the product are contributing towards the growth of regional market.
The prominent companies operating in the medical marijuana market are ABcann Medicinals, Inc., Aurora Cannabis, Inc., Canopy Growth Corp., Aphria, Inc., The Supreme Cannabis Co., Tilray and GW Pharmaceuticals.